Yekaterina Chudnovsky

CIK: 0001979324

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ELTX

Elicio Therapeutics, Inc.

Director10% Owner

IMMX

Immix Biopharma, Inc.

Director

XLO

Xilio Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ELTX
Elicio Therapeutics, Inc.
Aug 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
21.8K shares-
IMMX
Immix Biopharma, Inc.
May 22, 2026
Award(A)
Direct
6.3K shares-
IMMX
Immix Biopharma, Inc.
Jun 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
33K shares-
ELTX
Elicio Therapeutics, Inc.
Jun 3, 2025
Award(A)
Warrant (right to buy)
Indirect
103.2K shares-
ELTX
Elicio Therapeutics, Inc.
May 19, 2025
Award(A)
Stock Option (Right to Buy)
Direct
7.9K shares-
ELTX
Elicio Therapeutics, Inc.
Mar 5, 2025
Conversion(C)
Indirect
3.5M shares at avg. $5.81$20.3M
ELTX
Elicio Therapeutics, Inc.
Nov 21, 2024
Award(A)
Stock Option (Right to Buy)
Direct
4.1K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	21,750	-	-	Direct
May 22, 2026	IMMX Immix Biopharma, Inc.	Award(A)	6,250	-	$0	Direct
Jun 20, 2025	IMMX Immix Biopharma, Inc.	Award(A) Stock Option (Right to Buy)	33,000	-	-	Direct
Jun 3, 2025	ELTX Elicio Therapeutics, Inc.	Award(A) Warrant (right to buy)	103,225	-	-	Indirect
May 19, 2025	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	7,900	-	-	Direct
Mar 5, 2025	ELTX Elicio Therapeutics, Inc.	Conversion(C)	3,500,573	$5.81	$20,338,329	Indirect
Nov 21, 2024	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	4,100	-	-	Direct

1-7 of 7 transactions

About Chudnovsky Yekaterina

Chudnovsky Yekaterina (SEC CIK 0001979324) files insider reports with the SEC as Director of Elicio Therapeutics, Inc. (ELTX), Director of Immix Biopharma, Inc. (IMMX) and 10% Owner of Xilio Therapeutics, Inc. (XLO).

Signal8 holds 8 ownership filings by Chudnovsky Yekaterina (1 Form 3, 7 Form 4), filed between Sep 27, 2024 and Sep 2, 2026. Those filings report 7 transactions, from Nov 21, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chudnovsky Yekaterina's filings is in BOSTON, MA.

Recent filings by Chudnovsky Yekaterina

Aug 31, 2026: Grant or award of ELTX derivative securities (Form 4, code A).
May 22, 2026: Grant or award of IMMX shares (Form 4, code A).
Jun 20, 2025: Grant or award of IMMX derivative securities (Form 4, code A).
Jun 3, 2025: Grant or award of ELTX derivative securities (Form 4, code A).
May 19, 2025: Grant or award of ELTX derivative securities (Form 4, code A).

Other insiders filing for Elicio Therapeutics, Inc. (ELTX)

ADAMS JULIAN, Director
Ashe Carol Gail, Director
Nissenson Allen, Director
RUFFOLO ROBERT R, Director
WILSON KAREN J, Director
Venkatesan Jay, Director

How to read Form 4 transaction codes